Press release
Anti-obesity Drugs Market: The Next Big Innovation in Machinery Industry 2020||Novo Nordisk, Pfizer, Arena Pharmaceuticals, Roche
The report predicts the size of the global Anti-obesity Drugs market in terms of value and volume for the forecast period 2019-2026. As per the analysis provided in the report, the global Anti-obesity Drugs market is expected to rise at a CAGR of XX % between 2019 and 2026 to reach a valuation of US$ XX million/billion by the end of 2026. In 2018, the global Anti-obesity Drugs market attained a valuation of US$_ million/billion. The market researchers deeply analyze the global Anti-obesity Drugs industry landscape and the future prospects it is anticipated to create.
This publication includes key segmentations of the global Anti-obesity Drugs market on the basis of product, application, and geography (country/region). Each segment included in the report is studied in relation to different factors such as consumption, market share, value, growth rate, and production.
Get Sample Copy of This Report: https://www.qyresearch.com/sample-form/form/1609812/global-anti-obesity-drugs-market
The comparative results provided in the report allow readers to understand the difference between players and how they are competing against each other. The research study gives a detailed view of current and future trends and opportunities of the global Anti-obesity Drugs market. Market dynamics such as drivers and restraints are explained in the most detailed and easiest manner possible with the use of tables and graphs. Interested parties are expected to find important recommendations to improve their business in the global Anti-obesity Drugs market.
Readers can understand the overall profitability margin and sales volume of various products studied in the report. The report also provides the forecasted as well as historical annual growth rate and market share of the products offered in the global Anti-obesity Drugs market. The study on end-use application of products helps to understand the market growth of the products in terms of sales.
Global Anti-obesity Drugs Market by Product: Anti-obesity, Peripherally Acting Anti-obesity Drugs, Centrally Acting Anti-obesity Drugs
Global Anti-obesity Drugs Market by Application: Kids, Adults
The report also focuses on the geographical analysis of the global Anti-obesity Drugs market, where important regions and countries are studied in great detail.
Global Anti-obesity Drugs Market by Geography:
Methodology
Our analysts have created the report with the use of advanced primary and secondary research methodologies.
As part of primary research, they have conducted interviews with important industry leaders and focused on market understanding and competitive analysis by reviewing relevant documents, press releases, annual reports, and key products.
For secondary research, they have taken into account the statistical data from agencies, trade associations, and government websites, internet sources, technical writings, and recent trade information.
Key questions answered in the report:
What is the growth potential of the Anti-obesity Drugs market?
Which product segment will grab a lion’s share?
Which regional market will emerge as a frontrunner in the coming years?
Which application segment will grow at a robust rate?
What are the growth opportunities that may emerge in the Anti-obesity Drugs industry in the years to come?
What are the key challenges that the global Anti-obesity Drugs market may face in the future?
Which are the leading companies in the global Anti-obesity Drugs market?
Which are the key trends positively impacting the market growth?
Which are the growth strategies considered by the players to sustain hold in the global Anti-obesity Drugs market?
Enquire For Customization in the Report: https://www.qyresearch.com/customize-request/form/1609812/global-anti-obesity-drugs-market
Table Of Contents:
Table of Contents 1 Anti-obesity Drugs Market Overview
1.1 Anti-obesity Drugs Product Overview
1.2 Anti-obesity Drugs Market Segment by Type
1.2.1 Peripherally Acting Anti-obesity Drugs
1.2.2 Centrally Acting Anti-obesity Drugs
1.3 Global Anti-obesity Drugs Market Size by Type (2015-2026)
1.3.1 Global Anti-obesity Drugs Market Size Overview by Type (2015-2026)
1.3.2 Global Anti-obesity Drugs Historic Market Size Review by Type (2015-2020)
1.3.2.1 Global Anti-obesity Drugs Sales Market Share Breakdown by Type (2015-2026)
1.3.2.2 Global Anti-obesity Drugs Revenue Market Share Breakdown by Type (2015-2026)
1.3.2.3 Global Anti-obesity Drugs Average Selling Price (ASP) by Type (2015-2026)
1.3.3 Global Anti-obesity Drugs Market Size Forecast by Type (2021-2026)
1.3.3.1 Global Anti-obesity Drugs Sales Market Share Breakdown by Application (2021-2026)
1.3.3.2 Global Anti-obesity Drugs Revenue Market Share Breakdown by Application (2021-2026)
1.3.3.3 Global Anti-obesity Drugs Average Selling Price (ASP) by Application (2021-2026)
1.4 Key Regions Market Size Segment by Type (2015-2020)
1.4.1 North America Anti-obesity Drugs Sales Breakdown by Type (2015-2026)
1.4.2 Europe Anti-obesity Drugs Sales Breakdown by Type (2015-2026)
1.4.3 Asia-Pacific Anti-obesity Drugs Sales Breakdown by Type (2015-2026)
1.4.4 Latin America Anti-obesity Drugs Sales Breakdown by Type (2015-2026)
1.4.5 Middle East and Africa Anti-obesity Drugs Sales Breakdown by Type (2015-2026) 2 Global Anti-obesity Drugs Market Competition by Company
2.1 Global Top Players by Anti-obesity Drugs Sales (2015-2020)
2.2 Global Top Players by Anti-obesity Drugs Revenue (2015-2020)
2.3 Global Top Players Anti-obesity Drugs Average Selling Price (ASP) (2015-2020)
2.4 Global Top Manufacturers Anti-obesity Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-obesity Drugs Market Competitive Situation and Trends
2.5.1 Anti-obesity Drugs Market Concentration Rate (2015-2020)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-obesity Drugs Sales and Revenue in 2019
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-obesity Drugs as of 2019)
2.7 Date of Key Manufacturers Enter into Anti-obesity Drugs Market
2.8 Key Manufacturers Anti-obesity Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion 3 Global Anti-obesity Drugs Status and Outlook by Region (2015-2026)
3.1 Global Anti-obesity Drugs Market Size and CAGR by Region: 2015 VS 2020 VS 2026
3.2 Global Anti-obesity Drugs Market Size Market Share by Region (2015-2020)
3.2.1 Global Anti-obesity Drugs Sales Market Share by Region (2015-2020)
3.2.2 Global Anti-obesity Drugs Revenue Market Share by Region (2015-2020)
3.2.3 Global Anti-obesity Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
3.3 Global Anti-obesity Drugs Market Size Market Share by Region (2021-2026)
3.3.1 Global Anti-obesity Drugs Sales Market Share by Region (2021-2026)
3.3.2 Global Anti-obesity Drugs Revenue Market Share by Region (2021-2026)
3.3.3 Global Anti-obesity Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
3.4 North America Anti-obesity Drugs Market Size YoY Growth (2015-2026)
3.4.1 North America Anti-obesity Drugs Revenue YoY Growth (2015-2026)
3.4.2 North America Anti-obesity Drugs Sales YoY Growth (2015-2026)
3.5 Asia-Pacific Anti-obesity Drugs Market Size YoY Growth (2015-2026)
3.5.1 Asia-Pacific Anti-obesity Drugs Revenue YoY Growth (2015-2026)
3.5.2 Asia-Pacific Anti-obesity Drugs Sales YoY Growth (2015-2026)
3.6 Europe Anti-obesity Drugs Market Size YoY Growth (2015-2026)
3.6.1 Europe Anti-obesity Drugs Revenue YoY Growth (2015-2026)
3.6.2 Europe Anti-obesity Drugs Sales YoY Growth (2015-2026)
3.7 Latin America Anti-obesity Drugs Market Size YoY Growth (2015-2026)
3.7.1 Latin America Anti-obesity Drugs Revenue YoY Growth (2015-2026)
3.7.2 Latin America Anti-obesity Drugs Sales YoY Growth (2015-2026)
3.8 Middle East and Africa Anti-obesity Drugs Market Size YoY Growth (2015-2026)
3.8.1 Middle East and Africa Anti-obesity Drugs Revenue YoY Growth (2015-2026)
3.8.2 Middle East and Africa Anti-obesity Drugs Sales YoY Growth (2015-2026) 4 Global Anti-obesity Drugs by Application
4.1 Anti-obesity Drugs Segment by Application
4.1.1 Kids
4.1.2 Adults
4.2 Global Anti-obesity Drugs Sales by Application: 2015 VS 2020 VS 2026
4.3 Global Anti-obesity Drugs Historic Sales by Application (2015-2020)
4.4 Global Anti-obesity Drugs Forecasted Sales by Application (2021-2026)
4.5 Key Regions Anti-obesity Drugs Market Size by Application
4.5.1 North America Anti-obesity Drugs by Application
4.5.2 Europe Anti-obesity Drugs by Application
4.5.3 Asia-Pacific Anti-obesity Drugs by Application
4.5.4 Latin America Anti-obesity Drugs by Application
4.5.5 Middle East and Africa Anti-obesity Drugs by Application 5 North America Anti-obesity Drugs Market Size by Country (2015-2026)
5.1 North America Market Size Market Share by Country (2015-2020)
5.1.1 North America Anti-obesity Drugs Sales Market Share by Country (2015-2020)
5.1.2 North America Anti-obesity Drugs Revenue Market Share by Country (2015-2020)
5.2 North America Market Size Market Share by Country (2021-2026)
5.2.1 North America Anti-obesity Drugs Sales Market Share by Country (2021-2026)
5.2.2 North America Anti-obesity Drugs Revenue Market Share by Country (2021-2026)
5.3 North America Market Size YoY Growth by Country
5.3.1 U.S. Anti-obesity Drugs Market Size YoY Growth (2015-2026)
5.3.2 Canada Anti-obesity Drugs Market Size YoY Growth (2015-2026) 6 Europe Anti-obesity Drugs Market Size by Country (2015-2026)
6.1 Europe Market Size Market Share by Country (2015-2020)
6.1.1 Europe Anti-obesity Drugs Sales Market Share by Country (2015-2020)
6.1.2 Europe Anti-obesity Drugs Revenue Market Share by Country (2015-2020)
6.2 Europe Market Size Market Share by Country (2021-2026)
6.2.1 Europe Anti-obesity Drugs Sales Market Share by Country (2021-2026)
6.2.2 Europe Anti-obesity Drugs Revenue Market Share by Country (2021-2026)
6.3 Europe Market Size YoY Growth by Country
6.3.1 Germany Anti-obesity Drugs Market Size YoY Growth (2015-2026)
6.3.2 France Anti-obesity Drugs Market Size YoY Growth (2015-2026)
6.3.3 U.K. Anti-obesity Drugs Market Size YoY Growth (2015-2026)
6.3.4 Italy Anti-obesity Drugs Market Size YoY Growth (2015-2026)
6.3.5 Russia Anti-obesity Drugs Market Size YoY Growth (2015-2026) 7 Asia-Pacific Anti-obesity Drugs Market Size by Country (2015-2026)
7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)
7.1.1 Asia-Pacific Anti-obesity Drugs Sales Market Share by Country (2015-2020)
7.1.2 Asia-Pacific Anti-obesity Drugs Revenue Market Share by Country (2015-2020)
7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)
7.2.1 Asia-Pacific Anti-obesity Drugs Sales Market Share by Country (2021-2026)
7.2.2 Asia-Pacific Anti-obesity Drugs Revenue Market Share by Country (2021-2026)
7.3 Asia-Pacific Market Size YoY Growth by Country
7.3.1 China Anti-obesity Drugs Market Size YoY Growth (2015-2026)
7.3.2 Japan Anti-obesity Drugs Market Size YoY Growth (2015-2026)
7.3.3 South Korea Anti-obesity Drugs Market Size YoY Growth (2015-2026)
7.3.4 India Anti-obesity Drugs Market Size YoY Growth (2015-2026)
7.3.5 Australia Anti-obesity Drugs Market Size YoY Growth (2015-2026)
7.3.6 Taiwan Anti-obesity Drugs Market Size YoY Growth (2015-2026)
7.3.7 Indonesia Anti-obesity Drugs Market Size YoY Growth (2015-2026)
7.3.8 Thailand Anti-obesity Drugs Market Size YoY Growth (2015-2026)
7.3.9 Malaysia Anti-obesity Drugs Market Size YoY Growth (2015-2026)
7.3.10 Philippines Anti-obesity Drugs Market Size YoY Growth (2015-2026)
7.3.11 Vietnam Anti-obesity Drugs Market Size YoY Growth (2015-2026) 8 Latin America Anti-obesity Drugs Market Size by Country (2015-2026)
8.1 Latin America Market Size Market Share by Country (2015-2020)
8.1.1 Latin America Anti-obesity Drugs Sales Market Share by Country (2015-2020)
8.1.2 Latin America Anti-obesity Drugs Revenue Market Share by Country (2015-2020)
8.2 Latin America Market Size Market Share by Country (2021-2026)
8.2.1 Latin America Anti-obesity Drugs Sales Market Share by Country (2021-2026)
8.2.2 Latin America Anti-obesity Drugs Revenue Market Share by Country (2021-2026)
8.3 Latin America Market Size YoY Growth by Country
8.3.1 Mexico Anti-obesity Drugs Market Size YoY Growth (2015-2026)
8.3.2 Brazil Anti-obesity Drugs Market Size YoY Growth (2015-2026)
8.3.3 Argentina Anti-obesity Drugs Market Size YoY Growth (2015-2026) 9 Middle East and Africa Anti-obesity Drugs Market Size by Country (2015-2026)
9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)
9.1.1 Middle East and Africa Anti-obesity Drugs Sales Market Share by Country (2015-2020)
9.1.2 Middle East and Africa Anti-obesity Drugs Revenue Market Share by Country (2015-2020)
9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)
9.2.1 Middle East and Africa Anti-obesity Drugs Sales Market Share by Country (2021-2026)
9.2.2 Middle East and Africa Anti-obesity Drugs Revenue Market Share by Country (2021-2026)
9.3 Middle East and Africa Market Size YoY Growth by Country
9.3.1 Turkey Anti-obesity Drugs Market Size YoY Growth (2015-2026)
9.3.2 Saudi Arabia Anti-obesity Drugs Market Size YoY Growth (2015-2026)
9.3.3 U.A.E Anti-obesity Drugs Market Size YoY Growth (2015-2026) 10 Company Profiles and Key Figures in Anti-obesity Drugs Business
10.1 Merck
10.1.1 Merck Corporation Information
10.1.2 Merck Description, Business Overview and Total Revenue
10.1.3 Merck Anti-obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
10.1.4 Merck Anti-obesity Drugs Products Offered
10.1.5 Merck Recent Development
10.2 Novo Nordisk
10.2.1 Novo Nordisk Corporation Information
10.2.2 Novo Nordisk Description, Business Overview and Total Revenue
10.2.3 Novo Nordisk Anti-obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
10.2.5 Novo Nordisk Recent Development
10.3 Pfizer
10.3.1 Pfizer Corporation Information
10.3.2 Pfizer Description, Business Overview and Total Revenue
10.3.3 Pfizer Anti-obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
10.3.4 Pfizer Anti-obesity Drugs Products Offered
10.3.5 Pfizer Recent Development
10.4 Arena Pharmaceuticals
10.4.1 Arena Pharmaceuticals Corporation Information
10.4.2 Arena Pharmaceuticals Description, Business Overview and Total Revenue
10.4.3 Arena Pharmaceuticals Anti-obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
10.4.4 Arena Pharmaceuticals Anti-obesity Drugs Products Offered
10.4.5 Arena Pharmaceuticals Recent Development
10.5 Roche
10.5.1 Roche Corporation Information
10.5.2 Roche Description, Business Overview and Total Revenue
10.5.3 Roche Anti-obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
10.5.4 Roche Anti-obesity Drugs Products Offered
10.5.5 Roche Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Corporation Information
10.6.2 GlaxoSmithKline Description, Business Overview and Total Revenue
10.6.3 GlaxoSmithKline Anti-obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
10.6.4 GlaxoSmithKline Anti-obesity Drugs Products Offered
10.6.5 GlaxoSmithKline Recent Development
10.7 Orexigen Therapeutics
10.7.1 Orexigen Therapeutics Corporation Information
10.7.2 Orexigen Therapeutics Description, Business Overview and Total Revenue
10.7.3 Orexigen Therapeutics Anti-obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
10.7.4 Orexigen Therapeutics Anti-obesity Drugs Products Offered
10.7.5 Orexigen Therapeutics Recent Development
10.8 Vivus
10.8.1 Vivus Corporation Information
10.8.2 Vivus Description, Business Overview and Total Revenue
10.8.3 Vivus Anti-obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
10.8.4 Vivus Anti-obesity Drugs Products Offered
10.8.5 Vivus Recent Development
10.9 Amylin
10.9.1 Amylin Corporation Information
10.9.2 Amylin Description, Business Overview and Total Revenue
10.9.3 Amylin Anti-obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
10.9.4 Amylin Anti-obesity Drugs Products Offered
10.9.5 Amylin Recent Development
10.10 Alizyme
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Anti-obesity Drugs Product Category, Application and Specification
10.10.3 Alizyme Anti-obesity Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
10.10.4 Main Business Overview
10.10.5 Alizyme Recent Development
10.11 Boehringer Ingelheim
10.11.1 Boehringer Ingelheim Corporation Information
10.11.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
10.11.3 Boehringer Ingelheim Anti-obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
10.11.4 Boehringer Ingelheim Anti-obesity Drugs Products Offered
10.11.5 Boehringer Ingelheim Recent Development
10.12 Eisai
10.12.1 Eisai Corporation Information
10.12.2 Eisai Description, Business Overview and Total Revenue
10.12.3 Eisai Anti-obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
10.12.4 Eisai Anti-obesity Drugs Products Offered
10.12.5 Eisai Recent Development 11 Anti-obesity Drugs Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-obesity Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-obesity Drugs Industrial Chain Analysis
11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis
11.4.1 Market Opportunities and Drivers
11.4.2 Market Challenges
11.4.3 Market Risks
11.4.4 Porter’s Five Forces Analysis 12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Distributors
12.3 Downstream Customers 13 Research Findings and Conclusion 14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Author Details
14.4 Disclaimer
Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.”
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-obesity Drugs Market: The Next Big Innovation in Machinery Industry 2020||Novo Nordisk, Pfizer, Arena Pharmaceuticals, Roche here
News-ID: 2209950 • Views: …
More Releases from QY Research, Inc
Global Scandium Oxide Market Is Anticipated to Reach US$ 85 million by 2029, gro …
The global Scandium Oxide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Scandium Oxide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Global Magnesium Oxide Market Is Anticipated to Reach US$ 8163.3 million by 2029 …
The global Magnesium Oxide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Magnesium Oxide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Global Indium Market Is Anticipated to Reach US$ 674.7 million by 2029, growing …
The global Indium market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Indium market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global Indium Market.…
Global Surfactants Market Is Anticipated to Reach US$ 37320 million by 2029, gro …
The global Surfactants market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Surfactants market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global Surfactants Market.…
More Releases for Drugs
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
Prospect of Global Excipients Market Research Report 2017 with Application inclu …
ResearchMoz added Latest Research Report titled " Global Excipients Market Research Report 2017 " to it's Large Report database.
In this report, the global Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD),…
Drugs research: Misuse by shareholders of the drugs industry
A new textbook illustrates the complex and multi-faceted dimensions of evidence building in European drugs research. On one level, the authors have identified practical and philosophical challenges regarding knowledge production including, for example, measurements of the drugs problem; researching the online world; and interpreting on-site drug tests.
On another level, the authors have highlighted challenges regarding knowledge production such as the misuse of evidence by knowledge brokers and policymakers.…
